EV‐RNP promotes the specific accumulation of RNP in the liver, targeting p53 to upregulate the expression of apoptosis regulator and cyclin E1 (CcnE1).[80] This provides a potential means for the EV treatment of liver diseases with precision and tissue specificity. This evidence concerns the gene CCNE1 and liver disorder.